109
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Mutations in the colony stimulating factor 1 receptor ( CSF1R) cause hereditary diffuse leukoencephalopathy with spheroids

      research-article
      1 , * , 1 , 1 , 1 , 1 , 1 , 2 , 1 , 3 , 1 , 1 , 1 , 1 , 1 , 2 , 4 , 5 , 6 , 6 , 7 , 7 , 7 , 8 , 9 , 9 , 10 , 11 , 2 , 1 , 2 , 2 , 12 , 13 , 2 , 1 , 14 , 15 , 1 , 2
      Nature Genetics

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hereditary diffuse leukoencephalopathy with spheroids (HDLS) is an autosomal dominantly inherited central nervous system white matter disease with variable clinical presentations including personality and behavioral changes, dementia, depression, parkinsonism, seizures, and others 1, 2 . We combined genome-wide linkage analysis with exome sequencing and identified 14 different mutations affecting the tyrosine kinase domain of the colony stimulating factor receptor 1 (encoded by CSF1R) in 14 families affected by HDLS. In one kindred, the de novo occurrence of the mutation was confirmed. Follow-up sequencing analyses identified an additional CSF1R mutation in a patient clinically diagnosed with corticobasal syndrome (CBS). In vitro, CSF-1 stimulation resulted in the rapid autophosphorylation of selected tyrosine-residues in the kinase domain of wild-type but not mutant CSF1R, suggesting that HDLS may result from a partial loss of CSF1R function. Since CSF1R is a critical mediator of microglial proliferation and differentiation in the brain, our findings suggest an important role for microglial dysfunction in HDLS pathogenesis.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Oncogenic kinase signalling.

          Protein-tyrosine kinases (PTKs) are important regulators of intracellular signal-transduction pathways mediating development and multicellular communication in metazoans. Their activity is normally tightly controlled and regulated. Perturbation of PTK signalling by mutations and other genetic alterations results in deregulated kinase activity and malignant transformation. The lipid kinase phosphoinositide 3-OH kinase (PI(3)K) and some of its downstream targets, such as the protein-serine/threonine kinases Akt and p70 S6 kinase (p70S6K), are crucial effectors in oncogenic PTK signalling. This review emphasizes how oncogenic conversion of protein kinases results from perturbation of the normal autoinhibitory constraints on kinase activity and provides an update on our knowledge about the role of deregulated PI(3)K/Akt and mammalian target of rapamycin/p70S6K signalling in human malignancies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            CSF-1 regulation of the wandering macrophage: complexity in action.

            Most tissue macrophages and osteoclasts are regulated by colony-stimulating factor-1 (CSF-1, also known as macrophage CSF). The effects of CSF-1 are mediated by the CSF-1 receptor tyrosine kinase (CSF-1R), through autophosphorylation of CSF-1R and the subsequent phosphorylation of downstream molecules. Triggering this phosphorylation cascade increases gene transcription and protein translation, and induces cytoskeletal remodeling by several signaling pathways, leading to the survival, proliferation and differentiation of target cells. CSF-1-regulated tissue macrophages are important for innate immunity and for tissue development and function. Because CSF-1 regulates the survival, proliferation and chemotaxis of macrophages and supports their activation, this factor is involved in the pathogenesis of several diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.

              Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL; MIM 221770), also known as Nasu-Hakola disease, is a recessively inherited disease characterized by a combination of psychotic symptoms rapidly progressing to presenile dementia and bone cysts restricted to wrists and ankles. PLOSL has a global distribution, although most of the patients have been diagnosed in Finland and Japan, with an estimated population prevalence of 2x10-6 (ref. 2) in the Finns. We have previously identified a shared 153-kb ancestor haplotype in all Finnish disease alleles between markers D19S1175 and D19S608 on chromosome 19q13.1 (refs 5,6). Here we characterize the molecular defect in PLOSL by identifying one large deletion in all Finnish PLOSL alleles and another mutation in a Japanese patient, both representing loss-of-function mutations, in the gene encoding TYRO protein tyrosine kinase binding protein (TYROBP; formerly DAP12). TYROBP is a transmembrane protein that has been recognized as a key activating signal transduction element in natural killer (NK) cells. On the plasma membrane of NK cells, TYROBP associates with activating receptors recognizing major histocompatibility complex (MHC) class I molecules. No abnormalities in NK cell function were detected in PLOSL patients homozygous for a null allele of TYROBP.
                Bookmark

                Author and article information

                Journal
                9216904
                2419
                Nat Genet
                Nat. Genet.
                Nature Genetics
                1061-4036
                1546-1718
                7 November 2011
                25 December 2011
                01 August 2012
                : 44
                : 2
                : 200-205
                Affiliations
                [1 ]Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, USA
                [2 ]Department of Neurology, Mayo Clinic Florida, Jacksonville, Florida, USA
                [3 ]Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois (CHUV-UNIL), Lausanne, Switzerland
                [4 ]Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway
                [5 ]Department of Pathology, University of Aberdeen, Aberdeen, Scotland
                [6 ]Center for Neuropathology and Prion Research, Ludwig-Maximilians University Munich, Munich, Germany
                [7 ]Department of Neurology, Mayo Clinic Minnesota, Rochester, Minnesota, USA
                [8 ]Alzheimer’s Disease Research Center, Department of Neurology, Washington University School of Medicine, St Louis, Missouri, USA
                [9 ]Department of Pathology and Laboratory Medicine and Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, USA
                [10 ]Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
                [11 ]Department of Neurology, Wayne State University School of Medicine, Detroit, USA
                [12 ]HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA
                [13 ]Department of Radiology, Mayo Clinic Florida, Jacksonville, Florida, USA
                [14 ]Department of Pathology, Texas Tech University Health Sciences Center, Lubbock, Texas, USA
                [15 ]Department of Neurology, University of Kansas School of Medicine, Kansas City, USA
                Author notes
                [* ] Corresponding author’s contact information Department of Neuroscience, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224, Tel: (904)-953-6279, Fax: (904)-953-7370 rademakers.rosa@ 123456mayo.edu
                Article
                nihpa336734
                10.1038/ng.1027
                3267847
                22197934
                ae0a7507-4bc7-4ef5-b1fe-f8306cb88666

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Genetics
                Genetics

                Comments

                Comment on this article